Sikkema Reina, Koopmans Marion
Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands;
Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
Infect Ecol Epidemiol. 2016 Nov 29;6:33703. doi: 10.3402/iee.v6.33703. eCollection 2016.
The increase in emerging human infectious diseases that have a zoonotic origin and the increasing resistance of microorganisms to antimicrobial drugs have shown the need for collaborations between the human, animal and environmental health sectors. The One Health concept increasingly receives recognition from policy makers and researchers all over the world. This overview compiled research and education activities in the area of One Health in Western Europe (Austria, Belgium, France, Germany, Italy, Iceland, Ireland, Liechtenstein, Luxembourg, Monaco, the Netherlands, Portugal, Scandinavia, Spain, Switzerland, and the United Kingdom (UK), with a focus on infectious diseases. It can serve as a starting point for future initiatives and collaborations.
A literature search for 'One Health' was performed using National Center for Biotechnology Information and Google. Moreover, information from global and European policy documents was collected and a questionnaire was designed to gather current One Health research and training activities in Western Europe.
This overview shows that there is considerable recognition for One Health in Europe, although most educational initiatives are recent. In Europe, the One Health approach is currently mainly advocated in relation to antimicrobial resistance (AMR). Many countries have incorporated the One Health approach in their policy to fight AMR, and funding possibilities for AMR research increased significantly. The number of national and international multidisciplinary research networks in the area of zoonotic diseases and One Health is increasing.
Although One Health has gained recognition in Europe, often a One Health approach to research and education in the area of zoonotic diseases and AMR is not implemented. In many countries, collaboration between sectors is still lacking, and One Health activities are predominantly initiated by the veterinary sector. To facilitate the multidisciplinary approach that is needed to fight zoonotic diseases and AMR, exploring current barriers for collaboration is needed. Targeted funding can help address these boundaries and facilitate multidisciplinary research and training to fight both zoonotic diseases and AMR in Europe.
源自人畜共患病的新型人类传染病不断增加，微生物对抗菌药物的耐药性也日益增强，这表明人类、动物和环境卫生部门之间需要开展合作。“同一健康”概念越来越受到世界各地政策制定者和研究人员的认可。本综述汇编了西欧（奥地利、比利时、法国、德国、意大利、冰岛、爱尔兰、列支敦士登、卢森堡、摩纳哥、荷兰、葡萄牙、斯堪的纳维亚、西班牙、瑞士和英国）在“同一健康”领域的研究和教育活动，重点关注传染病。它可作为未来倡议和合作的起点。
利用美国国立生物技术信息中心和谷歌对“同一健康”进行文献检索。此外，收集了全球和欧洲政策文件中的信息，并设计了一份问卷以收集西欧当前的“同一健康”研究和培训活动。
本综述表明，“同一健康”在欧洲得到了相当程度的认可，尽管大多数教育举措都是最近才开展的。在欧洲，“同一健康”方法目前主要在抗菌药物耐药性（AMR）方面得到倡导。许多国家已将“同一健康”方法纳入其抗击AMR的政策中，AMR研究的资金可能性显著增加。人畜共患病和“同一健康”领域的国家和国际多学科研究网络数量正在增加。
尽管“同一健康”在欧洲已获得认可，但在人畜共患病和AMR领域，研究和教育的“同一健康”方法往往并未得到实施。在许多国家，部门间的合作仍然缺乏，“同一健康”活动主要由兽医部门发起。为促进抗击人畜共患病和AMR所需的多学科方法，需要探索当前的合作障碍。有针对性的资金可以帮助消除这些障碍，并促进多学科研究和培训，以在欧洲抗击人畜共患病和AMR。
